ACT-03
Post-Traumatic Epilepsy
Pre-clinicalActive
Key Facts
About Accure Therapeutics
Accure Therapeutics is a private, pre-revenue biotech focused on high-need CNS diseases. The company leverages a target-driven approach based on recent advances in neurobiology and neurodegeneration. Its strategy involves maturing early-stage programs to a validation point attractive for partnership or acquisition by larger pharmaceutical companies, supported by a seasoned executive team with deep CNS and biotech experience.
View full company profile